Replimune (REPL) Interest & Investment Income (2017 - 2025)
Replimune's (REPL) quarterly Interest & Investment Income came in at $2.8 million in Q4 2025, down 44.6% year-on-year from $5.1 million in Q4 2024, and down 23.0% quarter-over-quarter from $3.7 million in Q3 2025.
Replimune (REPL) Interest & Investment Income (2017 - 2025) Analysis & Trends
Replimune has disclosed Interest & Investment Income across 9 years of filings, most recently posting $2.8 million for Q4 2025.
- Interest & Investment Income for Q4 2025 came in at $2.8 million, down 44.6% year-over-year; the trailing twelve-month figure through Dec 2025 was $17.1 million (down 17.14% YoY), and the FY2025 annual result was $21.1 million, down 9.57% from the prior year.
- Interest & Investment Income came in at $2.8 million for Q4 2025 at Replimune, down from $3.7 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $6.2 million in Q2 2023 to a low of $80000.0 in Q3 2021.
- The 5-year median for Interest & Investment Income is $4.2 million (2024), against an average of $3.3 million.
- Across the five-year window, Interest & Investment Income slumped 84.68% in 2021 and jumped 4385.5% in 2023, its largest moves.
- Replimune's Interest & Investment Income stood at $87000.0 in 2021, then jumped by 2974.71% to $2.7 million in 2022, then soared by 112.56% to $5.7 million in 2023, then declined by 9.66% to $5.1 million in 2024, then slumped by 44.6% to $2.8 million in 2025.
- The last three Interest & Investment Income figures came in at $2.8 million (Q4 2025), $3.7 million (Q3 2025), and $4.7 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -14.79 Mn |
| 10 | Replimune | 780.01 Mn | 510.88 Mn | - | 2.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.85 Mn |
| Sep 30, 2025 | 3.70 Mn |
| Jun 30, 2025 | 4.71 Mn |
| Mar 31, 2025 | 5.88 Mn |
| Dec 31, 2024 | 5.14 Mn |
| Sep 30, 2024 | 5.39 Mn |
| Jun 30, 2024 | 4.71 Mn |
| Mar 31, 2024 | 5.43 Mn |
| Dec 31, 2023 | 5.69 Mn |
| Sep 30, 2023 | 6.05 Mn |
| Jun 30, 2023 | 6.19 Mn |
| Mar 31, 2023 | 5.88 Mn |
| Dec 31, 2022 | 2.68 Mn |
| Sep 30, 2022 | 1.11 Mn |
| Jun 30, 2022 | 343,000.00 |
| Mar 31, 2022 | 131,000.00 |
| Dec 31, 2021 | 87,000.00 |
| Sep 30, 2021 | 80,000.00 |
| Jun 30, 2021 | 92,000.00 |
| Mar 31, 2021 | 95,000.00 |